[go: up one dir, main page]

AR048355A1 - Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen - Google Patents

Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen

Info

Publication number
AR048355A1
AR048355A1 ARP050101262A ARP050101262A AR048355A1 AR 048355 A1 AR048355 A1 AR 048355A1 AR P050101262 A ARP050101262 A AR P050101262A AR P050101262 A ARP050101262 A AR P050101262A AR 048355 A1 AR048355 A1 AR 048355A1
Authority
AR
Argentina
Prior art keywords
association
compound
pharmaceutical compositions
antioxidant agent
heterociclical
Prior art date
Application number
ARP050101262A
Other languages
English (en)
Inventor
Louis Casteilla
Luc Penicaud
Pascal Berthelot
Catherine Dacquet
Daniel-Henri Caignard
Original Assignee
Centre Nat Rech Scient
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Servier Lab filed Critical Centre Nat Rech Scient
Publication of AR048355A1 publication Critical patent/AR048355A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicacion 1: Asociacion que comprende un compuesto que favorece el metabolismo corporal de lípidos y carbohidratos y un agente antioxidante. Reivindicacion 8: Composiciones farmacéuticas caracterizadas porque comprenden como ingredientes activo un compuesto que favorece el metabolismo de lípidos y carbohidratos en asociacion con un agente antioxidante de acuerdo con una de las reivindicaciones 1 a 7, solos o en combinacion con uno o más excipientes farmacéuticamente aceptables. Reivindicacion 11: Uso de una asociacion de acuerdo con una de las reivindicaciones 1 a 7, para la obtencion de composiciones farmacéuticas destinadas al tratamiento y/o prevencion de la obesidad.
ARP050101262A 2004-03-31 2005-03-31 Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen AR048355A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403359A FR2868313B1 (fr) 2004-03-31 2004-03-31 Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
AR048355A1 true AR048355A1 (es) 2006-04-19

Family

ID=34945535

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101262A AR048355A1 (es) 2004-03-31 2005-03-31 Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen

Country Status (18)

Country Link
US (1) US20070167502A1 (es)
EP (1) EP1729767A1 (es)
JP (1) JP2007530643A (es)
KR (1) KR100842567B1 (es)
CN (1) CN100536842C (es)
AR (1) AR048355A1 (es)
AU (1) AU2005232420B8 (es)
BR (1) BRPI0509389A (es)
CA (1) CA2563104A1 (es)
EA (1) EA012966B1 (es)
FR (1) FR2868313B1 (es)
GE (1) GEP20094637B (es)
MA (1) MA28467B1 (es)
MY (1) MY142039A (es)
NO (1) NO20064858L (es)
UA (1) UA86801C2 (es)
WO (1) WO2005099694A1 (es)
ZA (1) ZA200607798B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894965B1 (fr) * 2005-12-20 2008-01-25 Servier Lab Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2898125B1 (fr) * 2006-03-06 2008-06-13 Servier Lab Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015595A1 (en) * 1993-01-06 1994-07-21 Jemo-Pharm A/S Medium comprising a pharmacological/biological active substance
EP1024804A4 (en) * 1997-05-01 2001-03-21 Bristol Myers Squibb Co MTP INHIBITORS AND FAT-SOLUBLE VITAMIN THERAPEUTICS TO REDUCE SERUM LIPIDS
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
FR2804431A1 (fr) * 2000-02-02 2001-08-03 Adir Nouveaux derives heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE10044805A1 (de) * 2000-09-11 2002-04-04 Martin Klingenberg Verwendung von Coenzym Q zur Regulierung der Funktion der Entkopplerproteine
DE60117046T2 (de) * 2000-10-26 2006-09-28 Fournier Laboratories Ireland Ltd. Kombination von fenofibrat und von coenzym q10 für die behandlung der endothelial- missfunktion
JP2003116487A (ja) * 2001-10-15 2003-04-22 Beverly Corporation:Kk 痩身用食品
FR2845601B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Nouvelle association entre un compose heterocyclique et un agent antioxydant et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MA28467B1 (fr) 2007-03-01
KR100842567B1 (ko) 2008-07-01
KR20060133073A (ko) 2006-12-22
FR2868313B1 (fr) 2008-08-15
ZA200607798B (en) 2008-05-28
BRPI0509389A (pt) 2007-09-18
WO2005099694A1 (fr) 2005-10-27
EA200601632A1 (ru) 2007-04-27
GEP20094637B (en) 2009-03-10
WO2005099694A8 (fr) 2006-11-09
CA2563104A1 (fr) 2005-10-27
AU2005232420B2 (en) 2009-02-19
CN100536842C (zh) 2009-09-09
CN1938024A (zh) 2007-03-28
EP1729767A1 (fr) 2006-12-13
MY142039A (en) 2010-08-30
NO20064858L (no) 2006-10-25
EA012966B1 (ru) 2010-02-26
JP2007530643A (ja) 2007-11-01
HK1099689A1 (zh) 2008-10-24
AU2005232420A1 (en) 2005-10-27
UA86801C2 (ru) 2009-05-25
AU2005232420B8 (en) 2009-06-11
FR2868313A1 (fr) 2005-10-07
US20070167502A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
CO2021000174A2 (es) Composiciones tópicas para el alivio del dolor
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
AR032204A1 (es) Complejos de inclusion de ciclodextrina-drospirenona
ECSP088239A (es) Composición de liberación de fármaco sostenida
AR054064A1 (es) Composicio con ingrediente farmaceutico activo en base a canabinoide para formas de dosis mejoradas
HUP0301405A2 (hu) Fokozott oldékonyságú gyógyhatású komponenseket tartalmazó készítmények
AR067347A1 (es) Combinacion antihelmintica
CU23821A3 (es) Composición farmacéutica que comprende una difenilurea sustituida con omega-carboxiarilo para el tratamiento del cáncer
AR053651A1 (es) Tratamiento combinado de anticuerpo antictla4 r inhibidor de aromatasa para el cancer de mama
AR109263A2 (es) Composición que comprende moxidectina
ECSP088240A (es) Composición de trazodona para administración una vez por día
PL1680128T3 (pl) Heksafosforan mio-inozytolu do stosowania miejscowego
CO6531485A2 (es) Composiciones farmacéuticas sólidas que contienen un inhibidor de la integrasa
CO6220945A2 (es) Uso de una composicion que comprende formoterol y dipropianato de beclometasona para la prevencion y/o tratamiento de una exacerbacion de asma
ECSP066553A (es) Formas de administración masticables, no comprimidas dosificadas individualmente.
WO2006089114A3 (en) Methods and compositions for treating an anthrax toxin mediated condition
AR046402A1 (es) Combinacion de principio activo que comprende un compuesto 2,5-dihidrobencenosulfonico y un modulador de los canales de potasio
PE20130147A1 (es) Combinacion farmaceutica de teobromina y un agente antitusivo no opioide
ATE399558T1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
AR048355A1 (es) Asociacion entre un compuesto heterociclico y un agente antioxidante y las composiciones farmaceuticas que los contienen
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
ES2325291A1 (es) &#34;uso de un extracto de silybum marianum&#34;

Legal Events

Date Code Title Description
FB Suspension of granting procedure